
    
      Type of study: a randomized, single-blind, parallel-group, controlled clinical trial.

      Number of centers: 1 (Clermont-Ferrand)

      Patients

      Patients eligible for inclusion will be randomized to one of the two groups:

        -  APA + : patients will beneficiate of Personalized Physical Activity coaching program
           during 3 months (1 hour, twice by week, during 3 months)

        -  APA- : patients will do free practice of physical activity during 3 months.

      Study Performance Patients will be evaluated 3 times : at J0 (baseline, V1), 3 months after
      Personalized Physical Activity coaching program (J0+3M, V2), and 3 months after the end of
      the Personalized Physical Activity coaching program (J0+6M)

      V1:

        -  Signature of an informed consent form.

        -  Demographic and clinical characteristics (sex, age, disease duration, treatments).

      V1, V2, V3

        -  Neurological evaluation (Unified Parkinson Disease Rating Scale part III score)

        -  Evaluation of quality of life (Parkinson's Disease Questionnaire 39-item version
           (PDQ-39), participation to Daily life activities (Lawton and Brody Activities of Daily
           Living scale (IADL questionnaire25)

        -  Evaluation of performances for specific tests for balance (stabilometry), muscular
           strength (isometry)

        -  Evaluation of cardiorespiratory function (VO2pic et 6 min Walk Test)

        -  Evaluation of body composition (lean body mass/fat mass) with DEXA.

        -  Dropout rates at V2 and V3

        -  Evaluation of the activity with the eMOUVE application in a subgroup of patients.
    
  